You've lost me - the downward trend started 13 years ago for Novogen from something like $8 - long time between drinks - the share registry had grown through successive CR's the biggest in 2014/15 which doubled the registry from memory...
As far as bad news? GDC-0084 is planned to go into phase 2 trials within the the next 8 weeks - bad news really? You've lost me...
Name change, 1/10 the size of the current registry, GDC-0084 into phase 2 human trials, Cantrixil trial nearing 12 months in... yep I can't see the bad?
Ann: Novogen Annual Report and Corporate Governance Statement, page-42
-
- There are more pages in this discussion • 31 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)